Health Condition 1: L679- Hair color and hair shaft abnormality, unspecified
Conditions
Interventions
Intervention1: Greyverse, Euk 134 and Amisol trio: Application of the hair serum containing Greyverse, Euk 134 and Amisol trio on the scalp twice daily for 12 weeks, subject aged less than 25 years
Co
Sponsors
Apex laboratories private limited
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients aged less than 25 years diagnosed with premature canities attending the OPD 2.Patients who are willing to appear for regular follow ups and follow the prescribed treatment regularly. 3.Parents/guardians (legally authorized representative [LAR]) willing to provide written informed consent for patients aged less than 18 years. Patients between 18-25 years of age willing to provide written informed consent
Exclusion criteria
Exclusion criteria: 1.Patients known to be allergic to any of the components of the study medications. 2.History of any chronic systemic disease 3.Patients with known malignancy or those on chemotherapy. 4.Refusal to participate in the study. 5.Participated in a clinical trial in last 90 days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the efficacy of hair serum containing Greyverse, Euk 134 and Amisol trio in premature greying of hairTimepoint: after 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical photographs â?? taken in same position and with uniform illumination. Trichoscopy with video-dermoscope (Fotofinder) before and at the end of study period (Day 0 and 90) to analyse the outcomeTimepoint: after 3 months | — |
Countries
India
Contacts
Public ContactDr Rashmi Agarwal
CUTIS Academy of Cutaneous Sciences
Outcome results
None listed